Biomarkers of Kidney Failure and All-Cause Mortality in CKD.

Saved in:
Bibliographic Details
Title: Biomarkers of Kidney Failure and All-Cause Mortality in CKD.
Authors: Onoja A; Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, United Kingdom., McDonnell T; Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.; Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, United Kingdom., Annessi I; Division of Laboratory Medicine, Diagnostic Department, Faculty of Medicine, Geneva University Hospitals, Genève, Switzerland., Banks RE; School of Medicine, Leeds Institute of Medical Research, St James's University Hospital, Leeds, United Kingdom., Bergin M; Inflammatory Rheumatology FA, UCB Biopharma UK, Slough, United Kingdom., Cockwell P; Department of Renal Medicine, Queen Elizabeth Hospital, Institute of Inflammation and Ageing, University Hospitals of Birmingham, Birmingham, United Kingdom., Dusaulcy R; Division of Laboratory Medicine, Diagnostic Department, Faculty of Medicine, Geneva University Hospitals, Genève, Switzerland., Fraser SDS; Faculty of Medicine, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom., Johnson T; Experimental Renal Medicine, Human Metabolism and Oncology, The Medical School, University of Sheffield, Sheffield, United Kingdom., Kalra PA; Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.; Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, United Kingdom., Lemaître B; Division of Laboratory Medicine, Diagnostic Department, Faculty of Medicine, Geneva University Hospitals, Genève, Switzerland., Saleem M; Bristol Renal and Children's Renal Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Skroblin P; Evotec International GmbH, Göttingen, Germany., Soderberg M; Pathology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Taal MW; Department of Renal Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom.; Academic Unit for Translational Medical Sciences, Centre for Kidney Research and Innovation, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Unwin RJ; AstraZeneca Biopharmaceuticals, Cambridge Biomedical Campus, Cambridge, United Kingdom., Vuilleumier N; Division of Laboratory Medicine, Diagnostic Department, Faculty of Medicine, Geneva University Hospitals, Genève, Switzerland., Wheeler DC; Department of Renal Medicine, University College London, London, United Kingdom., Geifman N; Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, United Kingdom.
Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2025 Dec 01; Vol. 36 (12), pp. 2431-2444. Date of Electronic Publication: 2025 Jun 20.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1533-3450
DOI:10.1681/ASN.0000000767